These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 31826914)

  • 1. High-Negative Anti-
    Inoue M; Sawada N; Goto A; Shimazu T; Yamaji T; Iwasaki M; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):420-426. PubMed ID: 31826914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
    Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
    Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia.
    Leja M; Cine E; Rudzite D; Vilkoite I; Huttunen T; Daugule I; Rumba-Rozenfelde I; Pimanov S; Liepniece-Karele I; Pahomova J; Purmalis K; Eglitis J; Pirags V; Dzerve V; Erglis A
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1410-7. PubMed ID: 23114744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis.
    Watanabe M; Kato J; Inoue I; Yoshimura N; Yoshida T; Mukoubayashi C; Deguchi H; Enomoto S; Ueda K; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Tekeshita T; Mohara O; Ushijima T; Ichinose M
    Int J Cancer; 2012 Dec; 131(11):2632-42. PubMed ID: 22383377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and
    Koivurova OP; Koskela R; Blomster T; Ala-Rämi A; Lumme H; Kettunen O; Hukkanen J; Karttunen TJ; Mäkinen M; Ronkainen J; Syrjänen K
    Anticancer Res; 2021 Nov; 41(11):5527-5537. PubMed ID: 34732423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan.
    Ishikura N; Usui Y; Ito H; Kasugai Y; Oze I; Kato S; Yatabe Y; Nakamura S; Matsuo K
    Ann Hematol; 2019 Aug; 98(8):1981-1987. PubMed ID: 31177299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A Study to Determine the Optimum Antigens for the Serodiagnosis of Helicobacter Pylori Infection in Japanese Patients and the Association with IgG Subclass and Gastric Cancer].
    Kita M; Take S; Okada H; Matsushita O; Yokota K
    Rinsho Byori; 2015 Feb; 63(2):180-6. PubMed ID: 26529968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin G antibody against Helicobacter pylori is an accurate test for atrophic gastritis.
    Hung HH; Chen TS; Lin HC
    J Chin Med Assoc; 2010 Jul; 73(7):355-9. PubMed ID: 20688300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum pepsinogen and Helicobacter pylori infection--a Japanese population study.
    Toyoda K; Furusyo N; Ihara T; Ikezaki H; Urita Y; Hayashi J
    Eur J Clin Microbiol Infect Dis; 2012 Sep; 31(9):2117-24. PubMed ID: 22354521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum anti-Helicobacter pylori immunoglobulin G titer correlates with grade of histological gastritis, mucosal bacterial density, and levels of serum biomarkers.
    Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Yuan Y
    Scand J Gastroenterol; 2014 Mar; 49(3):259-66. PubMed ID: 24329006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males.
    Song M; Camargo MC; Weinstein SJ; Murphy G; Freedman ND; Koshiol J; Stolzenberg-Solomon RZ; Abnet CC; Männistö S; Albanes D; Rabkin CS
    Aliment Pharmacol Ther; 2018 Feb; 47(4):494-503. PubMed ID: 29243850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study.
    Kiso M; Yoshihara M; Ito M; Inoue K; Kato K; Nakajima S; Mabe K; Kobayashi M; Uemura N; Yada T; Oka M; Kawai T; Boda T; Kotachi T; Masuda K; Tanaka S; Chayama K
    Gastric Cancer; 2017 Sep; 20(5):764-771. PubMed ID: 28025702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of Helicobacter pylori Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study.
    Ikeda F; Shikata K; Hata J; Fukuhara M; Hirakawa Y; Ohara T; Mukai N; Nagata M; Yoshida D; Yonemoto K; Esaki M; Kitazono T; Kiyohara Y; Ninomiya T
    J Epidemiol; 2016 Dec; 26(12):629-636. PubMed ID: 27265836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk of gastric cancer dependent on serological markers of atrophic gastritis: cohort study].
    Reshetnikov OV; Openko TG; Simonova GI; Kurilovich SA; Maliushina SK; Ragino IuI; Voevoda MI
    Vopr Onkol; 2012; 58(5):644-8. PubMed ID: 23600281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association between AICDA 7888 C/T polymorphism, Helicobacter pylori seropositivity, and the risk of atrophic gastritis and gastric cancer in Japanese.
    Hishida A; Matsuo K; Goto Y; Mitsuda Y; Hiraki A; Naito M; Wakai K; Tajima K; Hamajima N
    Gastric Cancer; 2010 Mar; 13(1):43-9. PubMed ID: 20373075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GastroPanel® test for non-invasive diagnosis of atrophic gastritis in patients with dyspepsia.
    Masci E; Pellicano R; Mangiavillano B; Luigiano C; Stelitano L; Morace C; Viale E; Freschi M; Locatelli M; Ieri R; Cavallaro A; Testoni S; Testoni PA
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):79-83. PubMed ID: 24632770
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    MÄki M; SÖderstrÖm D; Paloheimo L; Hendolin P; Suovaniemi O; SyrjÄnen K
    Anticancer Res; 2020 Nov; 40(11):6387-6398. PubMed ID: 33109577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach.
    Iijima K; Abe Y; Kikuchi R; Koike T; Ohara S; Sipponen P; Shimosegawa T
    World J Gastroenterol; 2009 Feb; 15(7):853-9. PubMed ID: 19230047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Helicobacter pylori Immunoglobulin G Levels and Atrophic Gastritis Status on Risk of Metabolic Syndrome.
    Takeoka A; Tayama J; Yamasaki H; Kobayashi M; Ogawa S; Saigo T; Hayashida M; Shirabe S
    PLoS One; 2016; 11(11):e0166588. PubMed ID: 27851820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of autoimmune type atrophic corpus gastritis with Helicobacter pylori infection.
    Veijola LI; Oksanen AM; Sipponen PI; Rautelin HI
    World J Gastroenterol; 2010 Jan; 16(1):83-8. PubMed ID: 20039453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.